Carlsmed, Inc. Common Stock CARL Income Statement
| FY'25 | ||
|---|---|---|
| $50.51M+85.9% | ||
| $12.47M+75.2% | ||
| $38.04M+89.7% | ||
| 75.3%+1.5pp | ||
| $17.02M+19.0% | ||
| $35.03M+63.1% | ||
| $16.57M+97.4% | ||
| $68.61M+55.3% | ||
| -$30.57M-26.7% | ||
| -60.5%+28.3pp | ||
| $1.43M+8.3% | ||
| $940K+796% | ||
| -$29.63M-22.2% | ||
| -58.7%+30.6pp | ||
| —— | ||
| -$30.29M— | ||
| -60%— | ||
| -$30.57M-26.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Carlsmed, Inc. Common Stock's revenue?
- Carlsmed, Inc. Common Stock (CARL) generated $56.4M in revenue over the trailing twelve months, up 74.9% year over year.
- Is Carlsmed, Inc. Common Stock profitable?
- Carlsmed, Inc. Common Stock is not currently profitable: it reported a net loss of $32.6M over the trailing twelve months, a -57.8% net margin.
- What are Carlsmed, Inc. Common Stock's profit margins?
- Gross margin is 75.9% and operating margin is -60.5%, with a -57.8% net margin.
- What is Carlsmed, Inc. Common Stock's earnings per share?
- Carlsmed, Inc. Common Stock's diluted EPS over the trailing twelve months is $-3.66.
- Where does Carlsmed, Inc. Common Stock's income statement data come from?
- Every line is extracted from Carlsmed, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
